Anzeige
Mehr »
Donnerstag, 18.09.2025 - Börsentäglich über 12.000 News
Die Ethereum-Vorreiter: Wie Republic Technologies die Infrastruktur der Zukunft aufbaut
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
55 Leser
Artikel bewerten:
(0)

Innerscope Hearing Technologies, Inc.: Global Health & Pharma ('GHP') Recognises InnerScope Hearing Technologies (OTCQB: INND) In the 2019 Biotechnology Awards Winners

UNITED KINGDOM / ACCESSWIRE / March 25, 2019 / GHP Magazine has awarded InnerScope Hearing Technologies, ("InnerScope") Best Hearing Aid Manufacturer 2019 - USA & GHP Award for Innovation in Direct-to-Consumer Hearing Aid Delivery Process in the 2019 Biotechnology Awards.

Covering a variety of verticals, including bio agriculture, bio services, bio industrial and biopharmaceutical, the biotechnology market will be under the microscope in GHP Magazine's, 2019 Biotechnology Awards.

Boasting impressive market value growth with no signs of slowing, endeavours in biotechnology continue to make advancements in the laboratories as well as in the boardrooms, advancements which the lives of all, across the globe. It is for this reason, we at GHP are dedicated to bringing InnerScope's accomplishments to the forefront of the community with our award platform.

Since its inception in 2012, InnerScope has been disrupting the global hearing aid industry, which is worth more than 10 billion dollars.

Throughout the past seven years, InnerScope has been working towards achieving its mission: to develop new innovative technologies in Hearing Products for the 1.2 billion people around the world suffering from hearing impairment or hearing related issues. InnerScope is deploying its Hearing & Hearing Health Products to solve the numerous medical and cognitive issues caused by the world-wide epidemic of untreated hearing loss due to high cost and low accessibility of hearing aids and other related hearing products or hearing related treatment therapies. To find out more information of what led InnerScope to become what they are today and other award winners stories, click on the link 2019 Biotechnology Awards recipient supplement

Steve Simpson, Awards Coordinator commented on the awards and their deserving winners: "Through this awards programme, GHP honours a range of companies active within the sector. It is with great pride that I congratulate InnerScope Hearing Technologies for its hard work across the hearing aid development space and wish the team the best of luck for the future."

About GHP Magazine

Global Health and Pharma magazine is global information sharing platform & a multi-disciplinary member's community. The publication was established to enhance communication networks & collaboration across all themes and disciplines within three main categories; Human, Animal & Environmental Health. To find out more please visit http://www.ghp-news.com/

About InnerScope Hearing Technologies (OTCQB: INND)

InnerScope Hearing Technologies Inc. is a manufacturer and Direct-to-Consumer ("DTC") distributor/retailer of FDA-Registered Hearing Aids, Personal Sound Amplifiers Products, ("Hearing Products") Hearing Related Treatment Therapies, Doctor-Formulated Dietary Hearing Supplements and proprietary CDB Oil for Tinnitus ("Hearing Health Products") is a rapidly expanding consolidator of the hearing aid industry. Management is applying decades of profitable industry experience and technology to an antiquated and disjointed industry, unlocking scale and efficiency, which will serve all of InnerScope's stakeholders. Its direct-to-consumer model is revolutionizing the industry with its Walmart.com relationship representing a paramount shift in the consumption of hearing aids by the hearing impaired.

In addition, InnerScope plans to continue to open, acquire, and operate a physical chain of audiological and retail hearing device clinics. InnerScope's mission is to serve approximately 1.2 billion people around the globe that are suffering with 25 db or greater hearing loss across the entire hearing impaired vertical from R&D and manufacturing through direct consumer sales and services. To find out more please visit: https://www.innd.com/

SOURCE: Innerscope Hearing Technologies, Inc.



View source version on accesswire.com:
https://www.accesswire.com/540006/Global-Health-Pharma-GHP-Recognises-InnerScope-Hearing-Technologies-OTCQB-INND-In-the-2019-Biotechnology-Awards-Winners

© 2019 ACCESS Newswire
Solarbranche vor dem Mega-Comeback?
Lange galten Solaraktien als Liebling der Börse, dann kam der herbe Absturz: Zinsschock, Überkapazitäten aus China und ein Preisverfall, der selbst Marktführer wie SMA Solar, Enphase Energy oder SolarEdge massiv unter Druck setzte. Viele Anleger haben der Branche längst den Rücken gekehrt.

Doch genau das könnte jetzt die Chance sein!
Die Kombination aus KI-Explosion und Energiewende bringt die Branche zurück ins Rampenlicht:
  • Rechenzentren verschlingen Megawatt – Solarstrom bietet den günstigsten Preis je Kilowattstunde
  • Moderne Module liefern Wirkungsgrade wie Atomkraftwerke
  • hina bremst Preisdumping & pusht massiv den Ausbau
Gleichzeitig locken viele Solar-Aktien mit historischen Tiefstständen und massiven Short-Quoten, ein perfekter Nährboden für Kursrebound und Squeeze-Rally.

In unserem exklusiven Gratis-Report zeigen wir dir, welche 4 Solar-Aktien besonders vom Comeback profitieren dürften und warum jetzt der perfekte Zeitpunkt für einen Einstieg sein könnte.

Laden Sie jetzt den Spezialreport kostenlos herunter, bevor die Erholung am Markt beginnt!

Dieses Angebot gilt nur für kurze Zeit – also nicht zögern, jetzt sichern!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.